Finance
‘Game-changer’ GLP-1s could fix America’s obesity crisis—but 2 inequalities stand in the way
📋 Article Summary
52 words
Wells Fargo Industry Insights' Robin Wenzel says the drugs are rewriting healthcare economics, but the math doesn't "pencil out" too often. Wells Fargo Industry Insights' Robin Wenzel says the drugs are rewriting healthcare economics, but the math doesn't "pencil out" too often. Read the full story on Fortune via the link below.
Continue Reading
Full story on Fortune
🔗 You will be taken to fortune.com